Celltrion, Inc. Share Price
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,75,700.00 KRW | +1.68% |
|
-1.40% | +1.93% |
| 14/07 | Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar | MT |
| 07/07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| Market Cap | 40,29300Cr 2.7TCr 2.36TCr 2.18TCr 2.01TCr 3.8TCr 2,60200Cr 3.86TCr 26TCr 10TCr 1,27200Cr 10TCr 9.93TCr 4,38400Cr | P/E 2026 * |
27.1x | P/E 2027 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 4.23TCr 2.84Cr 2.48Cr 2.29Cr 2.11Cr 3.99Cr 273.43Cr 4.06Cr 27Cr 11Cr 133.65Cr 11Cr 10Cr 460.65Cr | EV / Sales 2026 * |
7.96x | EV / Sales 2027 * | 6.75x |
| Free-Float |
57.91% | Yield 2026 * |
0.42% | Yield 2027 * | 0.46% |
| 1 day | +1.68% | ||
| 1 week | -1.40% | ||
| Current month | +1.38% | ||
| 1 month | +1.56% | ||
| 3 months | -7.34% | ||
| 6 months | -12.77% | ||
| Current year | +1.93% |
| 1 week | 1,71,000 |  | 1,80,800 |
| 1 month | 1,59,200 | | 1,88,000 |
| Current year | 1,58,500 | | 2,39,047.62 |
| 1 year | 1,58,500 | | 2,39,047.62 |
| 3 years | 1,14,250.83 | | 2,39,047.62 |
| 5 years | 1,14,250.83 | | 2,47,058.06 |
| 10 years | 64,487.59 | | 3,25,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/01 | Sell | 1,000 | 0.0004% | |||
| 16/01 | Sell | 1,000 | 0.0004% | |||
| 16/01 | Sell | 500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | -1.40% | +4.23% | +27.34% | 2.66TCr | |
| -0.17% | +1.47% | +3.16% | +7.43% | 5.04TCr | |
| -0.32% | -2.71% | +388.28% | +593.80% | 3.93TCr | |
| +0.47% | +2.33% | +32.25% | -5.80% | 3.47TCr | |
| +1.65% | +3.07% | +15.37% | +57.23% | 3.41TCr | |
| +0.28% | -3.94% | - | - | 1.65TCr | |
| -0.34% | +0.32% | +70.67% | +115.76% | 1.53TCr | |
| +0.43% | +3.34% | +14.96% | +17.98% | 1.38TCr | |
| +0.84% | +2.24% | +16.20% | -30.96% | 1.29TCr | |
| +0.93% | -1.88% | +1,412.63% | +653.46% | 1.17TCr | |
| Average | +0.56% | -1.00% | +217.53% | +159.58% | 2.55TCr | |
| Weighted average by Cap. | +0.48% | -0.60% | +147.51% | +148.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,32100Cr 357.16Cr 312.27Cr 288.06Cr 264.8Cr 501.73Cr 34TCr 510.31Cr 3.44TCr 1.35TCr 17TCr 1.34TCr 1.31TCr 58TCr | 6,18100Cr 414.9Cr 362.75Cr 334.63Cr 307.61Cr 582.84Cr 40TCr 592.81Cr 3.99TCr 1.57TCr 20TCr 1.56TCr 1.52TCr 67TCr |
| Net income | 1,48400Cr 100Cr 87Cr 80Cr 74Cr 139.9Cr 9.58TCr 142.29Cr 958.89Cr 376.24Cr 4.68TCr 373.99Cr 365.79Cr 16TCr | 1,69800Cr 113.99Cr 100Cr 92Cr 85Cr 160.13Cr 11TCr 162.87Cr 1.1TCr 430.65Cr 5.36TCr 428.07Cr 418.69Cr 18TCr |
| Net Debt | 2,04100Cr 137.03Cr 119.81Cr 110.52Cr 101.6Cr 192.5Cr 13TCr 195.79Cr 1.32TCr 517.71Cr 6.44TCr 514.62Cr 503.34Cr 22TCr | 1,42700Cr 96Cr 84Cr 77Cr 71Cr 134.61Cr 9.22TCr 136.91Cr 922.62Cr 362.01Cr 4.51TCr 359.84Cr 351.96Cr 16TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | ₩1,75,700.00 | +1.68% | 4,91,182 |
| 14/26/14 | ₩1,72,800.00 | -1.31% | 7,10,511 |
| 13/26/13 | ₩1,75,100.00 | -0.06% | 6,46,548 |
| 10/26/10 | ₩1,75,200.00 | +1.21% | 4,35,099 |
| 09/26/09 | ₩1,73,100.00 | -2.09% | 6,09,649 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
